scholarly journals Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft tissue sarcomas

2021 ◽  
pp. clincanres.2480.2021
Author(s):  
Geraldine O'Sullivan Coyne ◽  
Shivaani Kummar ◽  
James Hu ◽  
Kristen Ganjoo ◽  
Warren A. Chow ◽  
...  
2009 ◽  
Vol 15 (S2) ◽  
pp. 16-17
Author(s):  
J Fagerland ◽  
S Morgan

Extended abstract of a paper presented at Microscopy and Microanalysis 2009 in Richmond, Virginia, USA, July 26 – July 30, 2009


Sign in / Sign up

Export Citation Format

Share Document